Hi folks, greeting to all
just stopped by while being on vacation in greece.
Some salient points from my point of view
1) Still i do not put so much significance in the
trading actions as of late, specially since the
volume is very small
2) Anvil would be stupid not to orchestre the
supposed new equity infusion in such a way that the
price for new shares is highest as possible for
obvious reasons. In doing so it is essential
to have a good timing in terms of market climate
and newsflow. So i do believe the issue will come
after reserves increase annoncement, additional positive exploration findings, proof stage 2 is working
as planed (even if this is based only on the outcome of one month after ramping up), announcment of accerlated Stage 111 development and a good promotion of the Gecamins deal all of wich can happen well until end of Octocber, this is just only another 2 months....May be even other unspected goodies happen
in that timeframe (World bank loan, zambian initiative etc)
3) The financing of the Gecamines deal can be a staged
approach (only a partly pay after conclusion) so
i do not see the immediate pressure to sell shares
at any price (I hope(d) these times are over).
4) In case the financing will come at a quiet low price
and not say AT LEAST at/above the latest issue
price of can 4.25 than not only the underwriters of
these issue will be disgruntled. I certainley would
be not be amused either and most likely change
my position and move to another stock.
The pessure is on management. Mr Turner always complained about the low price, this was also the reason to move to Toronto .Now it is time to be smart
and deliver and execute wisely.
- Forums
- ASX - By Stock
- institution game playing - silver credits too
AVM
advance metals limited
Add to My Watchlist
4.08%
!
4.7¢

Hi folks, greeting to alljust stopped by while being on vacation...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.7¢ |
Change
-0.002(4.08%) |
Mkt cap ! $12.45M |
Open | High | Low | Value | Volume |
4.8¢ | 4.9¢ | 4.7¢ | $78.91K | 1.662M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 185506 | 4.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.8¢ | 25000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 185506 | 0.047 |
1 | 580837 | 0.046 |
3 | 620451 | 0.045 |
2 | 460000 | 0.044 |
2 | 130000 | 0.043 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 25000 | 1 |
0.049 | 475000 | 2 |
0.050 | 655000 | 3 |
0.053 | 200000 | 1 |
0.054 | 114316 | 1 |
Last trade - 15.53pm 26/06/2025 (20 minute delay) ? |
Featured News
AVM (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online